Stockreport

INSYS Therapeutics Presents New Clinical Data from Long-Term Safety Study of CBD Oral Solution in Refractory Pediatric Epilepsy

INSYS THERAPEUTICS  (INSY) 
Last insys therapeutics earnings: 11/5 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.insysrx.com
PDF PHOENIX, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Pharmaceutical-grade cannabidiol (CBD) oral solution made by INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the develo [Read more]